Lipid-lowering and skin vascular responses in patients with hypercholesterolaemia and peripheral arterial obstructive disease

Abstract

Elevated blood cholesterol is a major risk factor for atherosclerosis. Recent studies show that lowering cholesterol reduces the risk of vascular disease, but the precise mechanisms for vascular improvement are not fully understood. Furthermore, it is not known whether the beneficial effects of cholesterol lowering extend to the skin microvasculature. In this unrandomized, open design study, we used iontophoresis and laser Doppler flowmetry to examine forearm skin perfusion in hypercholesterolaemic patients with PAOD before and after cholesterol-lowering therapy with fluvastatin.

Endothelium-dependent and -independent vasodilatation were measured following skin iontophoresis of acetylcholine (ACh) and sodium nitroprusside (SNP), respectively.

Before cholesterol-lowering, vascular responses to ACh and SNP were reduced significantly in patients compared with responses in control subjects (p, 0.001 and p, 0.05, ANOVA, respectively). Fluvastatin therapy (40 mg/day) for 24 weeks significantly reduced total cholesterol (7.3 6 0.3 to 6.0 6 0.2 mmol/l, p, 0.001) and LDL cholesterol (5.4 6 0.5 to 4.2 6 0.4 mmol/l, p, 0.01). Vasodilatation to SNP was significantly improved at week 24 (p, 0.05).

In patients with hypercholesterolaemia and PAOD, cholesterol-lowering with statin therapy significantly improved endothelium-independent vascular responses to SNP in skin microvessels. The application of the non-invasive techniques of iontophoresis and laser Doppler flowmetry may provide useful markers for the assessment of microvascular function in this group of patients.

Keywords

endothelium hypercholesterolaemia iontophoresis peripheral arterial obstructive disease skin vasodilatation

References

Levine GN , Keaney JF , Vita JA. Cholesterol reduction in cardiovascular disease. N Engl J Med 1995; 332: 512-521.

Brown G , Albers JJ , Fisher LD et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990; 323: 1289-1298.

Celemajer DS , Sorensen KE , Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1115.

Vita JA , Treasure CB , Nabel EG et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81: 491-497.

Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986; 8: 488-500.

Leung WH , Lau CP , Wong CK. Beneficial effect of cholesterol-lowering on coronary endothelium-dependent relaxation in hypercholesterolemic patients. Lancet 1993; 341: 1496-1500.

Egashira K , Hirooka Y , Kai H et al. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 1994; 89: 2519-2524.

Treasure CB , Klein JL , Weintraub WS et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332: 481-487.

Drexler H , Zeiher AM , Meinzer K , Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet 1991; 338: 1546-1550.

10.

Creager MA , Gallagher SJ , Girerd XJ , Coleman SM , Dzau VJ , Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992; 90: 1248-1253.

11.

Casino PR , Kilcoyne CM , Quyyumi AA , Hoeg JM , Panza JA. The role of nitic oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 1993; 88: 2541-2547.

12.

Ohara Y , Peterson TE , Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91: 2546-2551.

13.

Harrison DG , Ohara Y. Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis: implications for impaired vasomotion. Am J Cardiol 1995; 75: 75B-81B.

14.

Sorensen KE , Kristensen IB , Celermajer DS. Atherosclerosis in the human brachial artery. J Am Coll Cardiol 1997; 29(2): 318-322.

15.

Anderson TJ , Uehata A , Gerhard MD et al. Close relation of endothelial function in human coronary and peripheral circulation. JAm Coll Cardiol 1995; 26: 1235-1241.

16.

Creager M , Cooke JP , Mendelsohn ME et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990; 86: 228-234.

17.

Chowienczyk PJ , Watts GF , Cockcroft JR , Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hyper-cholesterolaemia. Lancet 1992; 340: 1430-1432.

18.

Sloan JB , Soltani K. Iontophoresis in dermatology. J Am Acad Dermatol 1986; 15(4): 671-684.

19.

Khan F , Litchfield SJ , McLaren M , Veale DJ , Littleford RC , Belch JJF. Oral L-arginine supplementation and cutaneous vascular responses in patients with primary Raynaud’s phenomenon. Arthritis Rheum 1997; 40(2): 352-357.

20.

Khan F , Davidson NC , Littleford RC , Litchfield SJ , Struthers AD , Belch JJF. Cutaneous vascular responses to acetylcholine are mediated by a prostacyclin-dependent mechanism in man. Vasc Med 1997; 2: 82-86.

21.

Goode GK , Heagerty AM. In vitro responses of human peripheral small arteries in hypercholesterolemia and effects of therapy. Circulation 1995; 91: 2898-2903.

22.

Khan F , Coffman JD. Enhanced cholinergic cutaneous vasodilation in Raynauds phenomenon. Circulation 1994; 89: 1183-1188.

23.

Noon JP , Walker BR , Hand MF , Webb DJ. Studies with iontophoretic administration of drugs to human dermal vessels in vivo: cholinergic vasodilatation is mediated by dilator prostanoids rather than nitric oxide. Br J Clin Pharmacol 1998; 45: 545-550.

24.

Grossman M , Jamieson MJ , Kellog DL et al. The effect of iontophoresis on the cutaneous vasculature: evidence for current-induced hyper-emia. Microvasc Res 1995; 50: 444-452.

25.

Morris SJ , Shore AC , Tooke JE. Responses of the skin microcirculation to acetylcholine and nitroprusside in patients with NIDDM. Diabetologia 1995; 38: 1337-1344.

26.

Panza JA , Quyyumi AA , Brush JE , Epstein SE. Abnormal endothelium-dependent relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-26.

27.

Cockcroft JR , Chowienczyk PJ , Benjamin N , Ritter JM. Preserved endothelium-dependent vasodilation in patients with essential hyper-tension. N Engl J Med 1994; 330: 1036-1040.

28.

Gerhard M , Roddy MA , Creager SJ , Creager MA. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 1996; 27: 849-853.

29.

Bossaller C , Habib GB , Yamamoto H , Williams C , Wells S , Henry PD. Impaired muscarine endothelium dependent relaxation and cyclic guanosine 59-monophosphate formation in artherosclerotic human coronary artery and rabbit aorta. J Clin Invest 1987; 79: 170-174.

30.

Casino PR , Kilcoyne CM , Cannon III RO , Quyyumi AA , Panza JA. Impaired endothelium-dependent vascular relaxation in patients with hypercholesterolemia extends beyond the muscarinic receptor. Am J Cardiol 1995; 75: 40-44.

31.

Minor RLJ , Myers PR , Guerra R , Bates JN , Harrison DG. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest 1990; 86: 2109-2116.

32.

Anderson TJ , Meredith IT , Yeung AC , Frei B , Selwyn AP , Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995; 332: 488-493.

33.

Schachter M. Non-lipid effects of statins. Br J Cardiol 1997; 4 (suppl 1): S8-S11.

34.

Laufs U , La Fata V , Plutzky J , Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998; 97: 1129-1135.